Tower Research Capital (TRC)’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.6K | Buy |
4,186
+2,757
| +193% | +$65K | ﹤0.01% | 2386 |
|
|
2025
Q1 | $34.3K | Sell |
1,429
-9,046
| -86% | -$217K | ﹤0.01% | 2513 |
|
|
2024
Q4 | $443K | Buy |
10,475
+10,235
| +4,265% | +$433K | 0.01% | 1153 |
|
|
2024
Q3 | $10.6K | Sell |
240
-5,667
| -96% | -$250K | ﹤0.01% | 3738 |
|
|
2024
Q2 | $214K | Buy |
5,907
+5,443
| +1,173% | +$197K | ﹤0.01% | 2021 |
|
|
2024
Q1 | $20K | Sell |
464
-7,831
| -94% | -$338K | ﹤0.01% | 2999 |
|
|
2023
Q4 | $128K | Buy |
8,295
+5,956
| +255% | +$91.6K | ﹤0.01% | 2445 |
|
|
2023
Q3 | $32.1K | Buy |
2,339
+411
| +21% | +$5.64K | ﹤0.01% | 2968 |
|
|
2023
Q2 | $30.9K | Sell |
1,928
-2,906
| -60% | -$46.6K | ﹤0.01% | 2976 |
|
|
2023
Q1 | $38K | Buy |
4,834
+4,303
| +810% | +$33.8K | ﹤0.01% | 2764 |
|
|
2022
Q4 | $10K | Sell |
531
-1,004
| -65% | -$18.9K | ﹤0.01% | 4089 |
|
|
2022
Q3 | $33K | Buy |
1,535
+105
| +7% | +$2.26K | ﹤0.01% | 3532 |
|
|
2022
Q2 | $19K | Buy |
1,430
+1,203
| +530% | +$16K | ﹤0.01% | 3863 |
|
|
2022
Q1 | $5K | Sell |
227
-311
| -58% | -$6.85K | ﹤0.01% | 5111 |
|
|
2021
Q4 | $14K | Sell |
538
-67
| -11% | -$1.74K | ﹤0.01% | 4115 |
|
|
2021
Q3 | $10K | Buy |
+605
| New | +$10K | ﹤0.01% | 4343 |
|